Your browser doesn't support javascript.
loading
Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.
Beecham, Ashley H; Amezcua, Lilyana; Chinea, Angel; Manrique, Clara P; Gomez, Lissette; Martinez, Andrea; Beecham, Gary W; Patsopoulos, Nikolaos A; Chitnis, Tanuja; Weiner, Howard L; De Jager, Philip L; Burchard, Esteban G; Lund, Brett T; Fitzgerald, Kathryn C; Calabresi, Peter A; Delgado, Silvia R; Oksenberg, Jorge R; McCauley, Jacob L.
Afiliación
  • Beecham AH; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
  • Amezcua L; Dr. John T. Macdonald Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
  • Chinea A; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
  • Manrique CP; San Juan MS Center, Guaynabo, Puerto Rico, United States of America.
  • Gomez L; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
  • Martinez A; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
  • Beecham GW; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
  • Patsopoulos NA; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
  • Chitnis T; Dr. John T. Macdonald Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
  • Weiner HL; Ann Romney Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA, United States of America.
  • De Jager PL; Ann Romney Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA, United States of America.
  • Burchard EG; Ann Romney Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA, United States of America.
  • Lund BT; Center For Translational & Computational Neuroimmunology and the Multiple Sclerosis Center, Department of Neurology, Columbia University Irving Medical Center, New York, NY, United States of America.
  • Fitzgerald KC; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, United States of America.
  • Calabresi PA; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
  • Delgado SR; Department of Neurology and The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Oksenberg JR; Department of Neurology and The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • McCauley JL; Multiple Sclerosis Division, Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
PLoS One ; 17(12): e0279132, 2022.
Article en En | MEDLINE | ID: mdl-36548255
ABSTRACT
The Major Histocompatibility Complex (MHC) makes the largest genetic contribution to multiple sclerosis (MS) susceptibility, with 32 independent effects across the region explaining 20% of the heritability in European populations. Variation is high across populations with allele frequency differences and population-specific risk alleles identified. We sought to identify MHC-specific MS susceptibility variants and assess the effect of ancestral risk modification within 2652 Latinx and Hispanic individuals as well as 2435 Black and African American individuals. We have identified several novel susceptibility alleles which are rare in European populations including HLA-B*5301, and we have utilized the differing linkage disequilibrium patterns inherent to these populations to identify an independent role for HLA-DRB1*1501 and HLA-DQB1*0602 on MS risk. We found a decrease in Native American ancestry in MS cases vs controls across the MHC, peaking near the previously identified MICB locus with a decrease of ~5.5% in Hispanics and ~0.4% in African Americans. We have identified several susceptibility variants, including within the MICB gene region, which show global ancestry risk modification and indicate ancestral differences which may be due in part to correlated environmental factors. We have also identified several susceptibility variants for which MS risk is modified by local ancestry and indicate true ancestral genetic differences; including HLA-DQB1*0602 for which MS risk for European allele carriers is almost two times the risk for African allele carriers. These results validate the importance of investigating MS susceptibility at an ancestral level and offer insight into the epidemiology of MS phenotypic diversity.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Complejo Mayor de Histocompatibilidad / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Complejo Mayor de Histocompatibilidad / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos